Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Jakobsen, Ane Storch ^a,b   Speyer, Helene ^a,b   Nørgaard, Hans Christian Brix ^c,d   Karlsen, Mette ^a,b   Birk, Merete ^c,d   Hjorthøj, Carsten ^a   Mors, Ole ^c,e   Krogh, Jesper ^a,b   Gluud, Christian ^f   Pisinger, Charlotta ^g   Nordentoft, Merete ^a,b  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^f Rigshospitalet   (Denmark)

^g Research for Prevention and Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HEMOGLOBIN A1C; LIPID; OLANZAPINE;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARE COORDINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LIFESTYLE COACHING; LIPID BLOOD LEVEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SMOKING; SMOKING CESSATION; SYMPTOM; WAIST CIRCUMFERENCE; WEIGHT; WELLBEING; ADOLESCENT; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; LIFESTYLE; MENTORING; MIDDLE AGED; OBESITY, ABDOMINAL; OVERWEIGHT; PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MENTORING; MIDDLE AGED; OBESITY, ABDOMINAL; OVERWEIGHT; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85030671179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0185881     Document Type: Article

References (39)

1. DE Hert M. et al., “Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.,” World Psychiatry, vol. 10, no. 1, pp. 52–77, 2011.
2. Hjorthøj C., Stürup A. E., Mcgrath J. J., and Nordentoft M., “Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis,” Lancet Psychiatry, vol. 366, no. published online Feb 21, pp. 1–7, 2017.
3. Bly M. J. et al., “Metabolic syndrome in bipolar disorder and schizophrenia: Dietary and lifestyle factors compared to the general population,” Bipolar Disord., 2014.
4. Beary M., Hodgson R., and Wildgust H. J., “A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications,” Journal of Psychopharma-cology. 2012.
5. Bruins J., Jörg F., Bruggeman R., Slooff C., Corpeleijn E., and Pijnenborg M., “The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: A meta-analysis,” PLoS One, 2014.
6. Bartels S. J. et al., “Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes,” Am. J. Psychiatry, vol. 172, no. 4, pp. 344–352, 2015.
7. Barry V. W., Baruth M., Beets M. W., Durstine J. L., Liu J., and Blair S. N., “Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis,” Prog. Cardiovasc. Dis., vol. 56, pp. 382–390, 2014.
8. Speyer H. et al., “Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity.,” BMC Psychiatry, vol. 15, no. 1, p. 119, 2015.
9. Speyer H. et al., “The CHANGE trial: No superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity,” World Psychiatry, 2016.
10. Wing J., Sartorius N., and Ustun T., Diagnosis and clinical measurement in psychiatry: a reference manual for SCAN. Cambridge: Cambridge University Press, 1998.
11. W. H. Organization, “Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation,” 2008.
12. Jørgensen T., Borch-Johnsen K., Thomsen T. F., Ibsen H., Glümer C., and Pisinger C., “A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.,” Eur. J. Cardiovasc. Prev. Rehabil., vol. 10, no. 5, pp. 377–86, Oct. 2003.
13. Thomsen T. F., Davidsen M., Ibsen H., Jorgensen T., Jensen G., and Borch-Johnsen K., “A New Method for Chd Prediction and Prevention Based on Regional Risk Scores and Randomized Clinical Trials; PRECARD(R) and the Copenhagen Risk Score,” Eur. J. Cardiovasc. Prev. Rehabil., vol. 8, no. 5, pp. 291–297, Oct. 2001.
14. Prochaska J. Q. and Diclemente C. C., “Stages of change in the modification of problem behaviors,” Prog. Behav. Modif., vol. 28, pp. 183–218, 1992.
15. Miller W. and Rollnick S., “The effectiveness and ineffectiveness of complex behavioral interventions: impact of treatment fidelity,” Contemp Clin Trials, vol. 37, pp. 234–241, 2014.
16. Stein L. and Test M., “Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation,” Arch Gen Psychiatry, vol. 37, pp. 392–397, 1980.
17. De Backer G., Ambrosini E., and Borch-Johnsen K., “European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice,” Eur. Heart J., vol. 24, pp. 1601–1610, 2003.
18. Andersen L., Groenvold M., and Jørgensen T., “Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing,” Scand. J. Public Health, vol. 38, pp. 707–714, 2010.
19. Etter J.-F., Vu Duc T., and Perneger T. V, “Validity of the Fagerström test for Nicotine Dependence and of the Heaviness of Smoking Index among relatively light smokers,” Test, vol. 94, no. February 1998, pp. 269–281, 1999.
20. Toft U., Kristoffersen L. H., Lau C., Borch-Johnsen K., and Jørgensen T., “The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study.,” Eur. J. Clin. Nutr., vol. 61, no. 2, pp. 270–8, Feb. 2007.
21. N. Andreasen and University of Iowa, “Scale for the Assessment of Positive Symptoms (SAPS).” Iowa City, 1984.
22. N. Andreasen and University of Iowa, “Scale for the Assessment of Negative Symptoms (SANS).” Iowa City, 1983.
23. Keefe R., Goldberg T., and Harvey P., “The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery,” Schizophr. Res., vol. 68, pp. 283–297, 2004.
24. Björkman T. and Svensson B., “Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA),” Nord. J. Psychiatry, vol. 59, no. 4, pp. 302–306, 2005.
25. Pedersen G., Hagtved K., and Karterud S., “Generalizability studies of the Global Assessment of Functioning—Split version,” Compr. Psychiatry, vol. 48, pp. 88–94, 2007.
26. Mossey J. and Shapiro E., “Self-rated health: a predictor of mortality among the elderly.,” Am. J. Public Health, vol. 72, no. 8, pp. 800–808, Aug. 1982.
27. Stahl S. M., Mignon L., and Meyer J. M., “Which comes first: Atypical antipsychotic treatment or cardiometabolic risk?,” Acta Psychiatrica Scandinavica. 2009.
28. Firth J., Rosenbaum S., Stubbs B., Gorczynski P., Yung A. R., and Vancampfort D., “Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis,” Psy-chol. Med., pp. 1–13, 2016.
29. Osborn D. P. J. et al., “Cardiovascular Risk Prediction Models for People With Severe Mental Illness: Results From the Prediction and Management of Cardiovascular Risk in People With Severe Mental Illnesses (PRIMROSE) Research Program.,” JAMA psychiatry, pp. 1–9, Dec. 2014.
30. Beaton H., “Approaches to analysis of dietary data: relationship between planned analyses and choice of methodology,” Am. J. Clin. Nutr., vol. 59, no. (suppl), p. 253S–61S, 1994.
31. U. Ischiel Træden, A. Olsen Zwisler, L. Møller, and H. Tønnesen, Disease prevention and health promotion at hospitals in Denmark. A survey. Netværk af forebyggende Sygehuse i Danmark, 2003.
32. Mastellos N., Gunn L., Felix L., Car J., and Majeed A., “Transtheoreticalmodel stages of change for dietary and physical exercisemodification in weight lossmanagement for overweight and obese adults (Review),” Cochrane Database Syst Rev, no. 2, pp. 1–89, 2014.
33. Riemsma R. P. et al., “Systematic review of the effectiveness of stage based interventions to promote smoking cessation.,” BMJ, vol. 326, no. 7400, pp. 1175–7, 2003.
34. Daumit G. L. et al., “A behavioral weight-loss intervention in persons with serious mental illness.,” N. Engl. J. Med., vol. 368, no. 17, pp. 1594–602, 2013.
35. Froelicher E., “Multifactorial Cardiac Rehabilitation: Education, Counseling and Behavioral Interventions,” in Cardiac Rehabilitation, Wenger N., Smith L, Froelicher E, and Comoss P., Eds. 1999, pp. 187–191.
36. Dombrowski S., Knittle K., Avenell A,Araujo-Soares V., and Sniehotta F., “Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials.,” Bmj, vol. 348, no. May, p. g2646, 2014.
37. Wing R. R. et al., “Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes,” N. Engl. J. Med., vol. 369, no. 2, pp. 145–154, 2013.
38. Wu R.-R. et al., “Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain,” JAMA, vol. 299, no. 2, pp. 185–193, 2008.
39. Neubeck L., Lowres N., Benjamin E. J., Ben Freedman S., Coorey G., and Redfern J., “The mobile revolution-using smartphone apps to prevent cardiovascular disease.,” Nat. Rev. Cardiol., vol. 12, no. 6, pp. 350–360, 2015.